| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a5511d171c3e1eb82c61cf7e5ad1663 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2570-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-92 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-92 |
| filingDate |
2022-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a3872a2f949a8a726fce018efea9623c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c88d2e39387baa7d4b4fc2177defe1f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_94585f47e0368d24065b84afca26426e |
| publicationDate |
2022-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2022171763-A1 |
| titleOfInvention |
Medium-chain fatty acyls and phospholipids as biomarkers for cardiovascular diseases |
| abstract |
The present invention relates to the use of lipid compounds comprising at least one medium chain fatty acid as biomarkers for diseases which are due to or accompanied by fatty acid oxidation disorder. The present invention furthermore relates to methods of assessing the risk to develop said diseases by determining the lipid compounds in samples. |
| priorityDate |
2021-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |